top of page
CK_cb2000000572.jpg

Company News

최고의 기술력을 기반으로 차세대 분자진단 시장을 앞서 나갑니다.

BioTNS selected as host of gov't's ultra-precision digital PCR project

  • Jun 27
  • 1 min read

BioTNS, a Korean molecular diagnostics company, was selected as the host organization to spearhead a 30 billion won ($20 million) government program to set up technical standards for ultra-precision digital PCR diagnostics.




 
 
bottom of page